✦ LIBER ✦

Anticardiolipin, glutamic acid decarboxylase, and antinuclear antibodies in epileptic patients

✍ Scribed by A. Verrotti; R. Greco; E. Altobelli; G. Latini; G. Morgese; F. Chiarelli

Publisher: Springer
Year: 2003
Tongue: English
Weight: 47 KB
Volume: 3
Category: Article
ISSN: 0372-8722
DOI: 10.1007/s102380300013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glutamic acid decarboxylase antibodies,

Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients

✍ G. Sundkvist; L. A. Velloso; O. Kämpe; S. L. Rabinowe; S. A. Ivarsson; B. Lilja; 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 859 KB

Glutamic acid decarboxylase antibodies i

Glutamic acid decarboxylase antibodies in Satoyoshi syndrome

✍ Gea Drost; Aad Verrips; Herbert Hooijkaas; Machiel Zwarts 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Glutamic acid decarboxylase antibodies i

Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes

✍ Pasquale Striano; Giuseppe Perruolo; Luca Errichiello; Pietro Formisano; Frances 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

colleagues' concern that there may be bias toward patients with more progressive disease in the control group compared with the treated group appears unlikely. The 20% of patients in the control group who had discontinued immunomodulatory or immunosuppressive treatment in the first 3 to 6 weeks bec

Antibodies to Glutamic Acid Decarboxylas

Antibodies to Glutamic Acid Decarboxylase in Japanese Diabetic Patients with Secondary Failure of Oral Hypoglycaemic Therapy

✍ Fukui, M.; Nakano, K.; Shigeta, H.; Yoshimori, K.; Fujii, M.; Kitagawa, Y.; Mori 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Some patients with non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) are positive for antibodies to glutamic acid decarboxylase (anti-GAD), which have been shown to be a useful marker for the diagnosis and prediction of insulin-dependent (Type 1) diabetes mellitus (IDDM). Anti-GAD positive NI

Glutamic acid decarboxylase antibodies a

Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression

✍ C. Jaeger; B. J. Hering; E. Hatziagelaki; K. Federlin; R. G. Bretzel 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 52 KB

Elimination of islet cell antibodies and

Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus

✍ W. O. Richter; M. G. Donner; P. Schwandt 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Islet cell antibodies and glutamic acid decarboxylase II (GAD II) antibodies have been discussed in the autoimmune pathogenesis of insulin-dependent diabetes mellitus (IDDM). Hence, immunosuppressants, intravenous immunoglobulins, and plasmapheresis have been used in an effort to modulate autoimmune